Non-alcoholic fatty liver disease (NAFLD) affects up to nearly a third of the Western population and has been inconsistently associated with cardiovascular diseases (CVDs). Therefore, we conducted a comprehensive meta-analysis to quantify the correlation of NAFLD with all major vascular diseases, acute coronary syndrome (ACS), subclinical atherosclerosis and endothelial dysfunction.
Methods
We searched PubMed and Embase for studies looking at the relationship between NAFLD and cardiovascular diseases published through September 2023. The parameters we used to assess cardiovascular diseases include acute coronary syndrome, brachial flow-mediated dilatation (FMD), serum asymmetric dimethylarginine (ADMA), carotid intima-media thickness (CIMT), and carotid stenosis (>50%). Data from these studies were then collected and meta-analysis was performed using the random effects model. RevMan v5.4 was used for statistical analysis.
Results
We interrogated a total of 114 publications which met our inclusion criteria. NAFLD patients showed statistically significant reduction in FMD% [MD: −4.83 (95% CI: −5.84 to 3.81, p < .00001)] and increased serum ADMA [MD: 0.08 (95% CI: 0.05–0.11, p < .00001)]. Mean CIMT was also increased in NAFLD patients [MD 0.13 (95% CI: 0.12–0.14, p < .00001)]. NAFLD showed a higher prevalence of pathological CIMT [MD: 0.11 (95% CI: 0.10–0.12, p < .00001)] and increased carotid plaques [OR: 2.08 (95% CI: 1.52–2.86, p < .00001)]. Furthermore, we demonstrated statistically significant increase in cardiovascular diseases among NAFLD patients compared to controls [OR: 1.92 (95% CI: 1.53–2.41, p < .00001)].
Conclusion
NAFLD is a strong predictor for endothelial dysfunction, subclinical atherosclerosis and cardiovascular disease. Further studies are required to determine whether incidental findings of fatty liver on abdominal ultrasonography should prompt the need for detailed assessment of other CVD risk factors.
SchwengerKJAllardJP. Clinical approaches to non-alcoholic fatty liver disease. World J Gastroenterol2014; 20: 1712–1723.
2.
ChalasaniNYounossiZLavineJE, et al.The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology2012; 55: 2005–2023.
WeberCNoelsH. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med2011; 17: 1410–1422.
7.
AdamsLALindorKD. Nonalcoholic fatty liver disease. Ann Epidemiol2007; 17: 863–869.
8.
BreaAMosqueraDMartínE, et al.Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol2005; 25: 1045–1050.
9.
TargherGBertoliniLPadovaniR, et al.Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care2007; 30: 1212–1218.
10.
TziomalosKGiampatzisVBouzianaSD, et al.Association between nonalcoholic fatty liver disease and acute ischemic stroke severity and outcome. World J Hepatol2013; 5: 621–626.
11.
CetindağlıIKaraMTanogluA, et al.Evaluation of endothelial dysfunction in patients with nonalcoholic fatty liver disease: association of selenoprotein P with carotid intima-media thickness and endothelium-dependent vasodilation. Clin Res Hepatol Gastroenterol2017; 41: 516–524.
12.
KarakurtFCarliogluAKoktenerA, et al.Relationship between cerebral arterial pulsatility and carotid intima media thickness in diabetic and non-diabetic patients with non-alcoholic fatty liver disease. J Endocrinol Invest2009; 32: 63–68.
13.
KucukazmanMAtaNYavuzB, et al.Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol2013; 25: 147–151.
14.
ChiangCHHuangPHChungFP, et al.Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease. PLoS One2012; 7: e31799.
15.
HacihamdioğluBOkutanVYozgatY, et al.Abdominal obesity is an independent risk factor for increased carotid intima-media thickness in obese children. Turk J Pediatr2011; 53: 48–54.
16.
ArincHSarliBBaktirAO, et al.Serum gamma glutamyl transferase and alanine transaminase concentrations predict endothelial dysfunction in patients with non-alcoholic steatohepatitis. Ups J Med Sci2013; 118: 228–234.
17.
Sayki ArslanMTurhanSDincerI, et al.A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with non-alcoholic fatty liver disease. Diabetol Metab Syndr2014; 6: 109.
18.
ColakYSenatesEYesilA, et al.Assessment of endothelial function in patients with nonalcoholic fatty liver disease. Endocrine2013; 43: 100–107.
19.
GuleriaADusejaAKalraN, et al.Patients with non-alcoholic fatty liver disease (NAFLD) have an increased risk of atherosclerosis and cardiovascular disease. Trop Gastroenterol2013; 34: 74–82.
20.
LiXShiHWangZ, et al.Arterial stiffness is increased in nondiabetic, nonhypertensive postmenopausal women with nonalcoholic fatty liver disease. J Hypertens2017; 35: 1226–1234.
21.
NarayanJDasHSNathP, et al.Endothelial dysfunction, a marker of atherosclerosis, is independent of metabolic syndrome in NAFLD patients. Int J Hepatol2020: 1825142. doi:https://doi.org/10.1155/2020/1825142
22.
OzturkKUygunAGulerAK, et al.Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men. Atherosclerosis2015; 240: 380–386.
23.
SapmazFUzmanMBasyigitS, et al.Steatosis grade is the most important risk factor for development of endothelial dysfunction in NAFLD. Medicine (Baltimore)2016; 95: e3280.
24.
SenturkOKocamanOHulaguS, et al.Endothelial dysfunction in Turkish patients with non-alcoholic fatty liver disease. Intern Med J2008; 38: 183–189.
25.
ThakurMLSharmaSKumarA, et al.Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians. Atherosclerosis2012; 223: 507–511.
26.
VillanovaNMoscatielloSRamilliS, et al.Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology2005; 42: 473–480.
27.
VlachopoulosCManesisEBaouK, et al.Increased arterial stiffness and impaired endothelial function in nonalcoholic fatty liver disease: a pilot study. Am J Hypertens2010; 23: 1183–1189.
28.
KasumovTEdmisonJMDasarathyS, et al.Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease. Metabolism2011; 60: 776–781.
29.
ShaikhAHAatifSAhmedT. Carotid intima-Media thickness in patients with non-alcoholic fatty liver disease. J Basic Appl Sci2013; 9: 333.
30.
MohammadiASedaniHHGhasemi-RadM. Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease. Vasc Health Risk Manag2011; 7: 661–665.
31.
AgarwalAKJainVSinglaS, et al.Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. J Assoc Physicians India2011; 59: 351–354.
32.
AlbrickerACLCoutoCANunesMCP, et al.Carotid artery intima-Media thickness and nonalcoholic fatty liver disease severity. J Cardiovasc Dis Diagn2014; 2: 2.
33.
AlgaremNHAminMAFawziMM,et al.Carotid Intima Media Thickness (CIMT) in Nondiabetic Patients with non Alcoholic Fatty Liver Disease (NAFLD). Med J Cairo Univ2011; 79(1): 491–496.
34.
AlpHKaraarslanSSelver EklioğluB, et al.Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents. Can J Cardiol2013; 29: 1118–1125.
35.
AygunCKocamanOSahinT, et al.Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease. Dig Dis Sci2008; 53: 1352–1357.
36.
BaouKVlachopoulosCManesisE, et al.P2.33: adiponectin hormone, hypertension and endothelial dysfunction in non-alcoholic fatty liver disease patients. Artery Res2008; 2: 114.
37.
BaşarOAkbalEKöklüS, et al.Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis. Herz2013; 38: 417–422.
38.
BreaAMosqueraDMartínE, et al.Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case–control study. Arterioscler, Thromb, Vasc Biol2005; 25: 1045–1050.
39.
Li-YingCLi-ZhengFQiao-HuaQ,et al.ASSA13-10-11 Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis. Heart2013; 99: A45.
40.
ChoiSYKimDKangJH, et al.Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis. Korean J Hepatol2008; 14: 77–88.
41.
ColakYKarabayCYTuncerI, et al.Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol2012; 24: 613–618.
42.
DemirciogluFKoçyigitAArslanN, et al.Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr2008; 47: 68–75.
43.
DoganTOzturkKCelikkanatS, et al.Comparison of anthropometric measurements for prediction of the atherosclerosis and liver histology in young adults with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol2019; 31: 1460–1466.
44.
EbrahimiRShanakiMMohassel AzadiS, et al.Low level of adiponectin predicts the development of nonalcoholic fatty liver disease: is it irrespective to visceral adiposity index, visceral adipose tissue thickness and other obesity indices?Arch Physiol Biochem2022; 128(1): 24–31.
45.
FracanzaniALBurdickLRaselliS, et al.Carotid artery intima-media thickness in nonalcoholic fatty liver disease. Am J Med2008; 121: 72–78.
46.
FracanzaniALTiraboschiSPisanoG, et al.Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up. Atherosclerosis2016; 246: 208–213.
47.
GökçeSAtbiniciZAycanZ, et al.The relationship between pediatric nonalcoholic fatty liver disease and cardiovascular risk factors and increased risk of atherosclerosis in obese children. Pediatr Cardiol2013; 34: 308–315.
48.
KilcilerGGencHTapanS, et al.Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease. Ups J Med Sci2010; 115: 253–259.
49.
GummessonAStrömbergUSchmidtC, et al.Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: a cross-sectional, population-based study in middle-aged subjects. PLoS One2018; 13: e0202666.
50.
GuoKZhangLLuJ, et al.Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes. J Diabetes Complications2017; 31: 80–85.
51.
GencHDogruTCelebiG, et al.Non-alcoholic fatty liver disease per se is not associated with carotid atherosclerosis. GüLhane Tip Dergisi2013; 55: 84.
52.
HanafiMCinaMZakerkishM, et al.Correlation between non-alcoholic fatty liver disease and carotid intima-Media thickness in patient with type II diabetes. Int J Osteoporosis Metab Disord2015; 8: 35–41.
53.
HanHGaoYXuL. The association between nonalcoholic fatty liver disease of the older and carotid atherosclerosis. J Aerospace Med2012; 1: 31–34.
54.
HuangYBiYXuM, et al.Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese. Arterioscler Thromb Vasc Biol2012; 32: 2321–2326.
55.
JosefPAliIArielP, et al.Relationship between retinal vascular caliber and coronary artery disease in patients with non-alcoholic fatty liver disease (NAFLD). Int J Environ Res Public Health2013; 10: 3409–3423.
56.
KangJHIm ChoKKimSM, et al.Relationship between nonalcoholic fatty liver disease and carotid artery atherosclerosis beyond metabolic disorders in non-diabetic patients. J Cardiovasc Ultrasound2012; 20: 126.
57.
KemalogluCKemalogluMD. Non alcoholic fatty liver disease is a predictor of subclinical carotid atherosclerosis in the presence of metabolic syndrome. Nepalese Heart J2019; 16: 39–45.
58.
KeumSHLeeKMJungSP. Nonalcoholic fatty liver disease as a risk factor for cardiovascular disease: using the estimation of Framingham risk score and carotid artherosclerosis. Korean J Health Promot2012; 12: 163–169.
59.
KimHCKimDJHuhKB. Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis2009; 204: 521–525.
60.
KimKSOhHJKimDJ, et al.The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels. Endocr J2013; 60: 1295–1301.
61.
KimNHParkJKimSH, et al.Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population. Heart2014; 100: 938–943.
62.
KimS-KChoiYJHuhBW, et al.Nonalcoholic fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance. J Clin Endocrinol Metab2014; 99: 1879–1884.
63.
KootBGde GrootEvan der Baan-SlootwegOH, et al.Nonalcoholic fatty liver disease and cardiovascular risk in children with obesity. Obesity (Silver Spring)2015; 23: 1239–1243.
64.
Sathish KumarASridharKSrinivasM, et al.Assessment of carotid lesions in nonalcoholic fatty liver disease patients. J Med Sci Clin Res2014; 2(11): 2888–2901.
65.
LinM-XLuoM-QChenZ-C, et al.Study of the relationship between nonalcoholic fatty liver disease and carotid atherosclerosis in type 2 diabetics. Chin J Health Laboratory Technol2010; 11: 2854–2855.
66.
LiuLRFuJFLiangL,et al.[Relationship between nonalcoholic fatty liver disease and cardiovascular disease in children with obesity]. Zhongguo Dang Dai Er Ke Za Zhi2010; 12: 547–550.
67.
MikolasevicIRackiSZaputovicL, et al.Nonalcoholic fatty liver disease (NAFLD) and cardiovascular risk in renal transplant recipients. Kidney Blood Pressure Res2014; 39: 308–314.
68.
MohammadiASedaniHHGhasemi-RadM. Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease. Vasc Health Risk Manag2011; 7: 661.
69.
MohammadzadehAShahkaramiVShakibaM, et al.Association of non-alcoholic fatty liver disease with increased carotid intima-media thickness considering other cardiovascular risk factors. Iran J Radiol2019; 16: e14260.
70.
NahandiMZKhoshbatenMRamazanzadehE, et al.Effect of non-alcoholic fatty liver disease on carotid artery intima-media thickness as a risk factor for atherosclerosis. Gastroenterol Hepatol Bed Bench2014; 7: 55–62.
71.
NeriSSignorelliSScuderiR, et al.Carotid intima-media thickness and liver histology in hemodialysis patients with nonalcoholic fatty liver disease. Int J Angiol2011; 20: 149.
72.
OniEBudoffMJZebI, et al.Nonalcoholic fatty liver disease is associated with arterial distensibility and carotid intima-media thickness: (from the multi-ethnic study of atherosclerosis). Am J Cardiol2019; 124: 534–538.
73.
OzturkKDoganTCelikkanatS, et al.The association of fatty pancreas with subclinical atherosclerosis in nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol2018; 30: 411–417.
74.
PaganoAVecchioCGiangrecoE,et al.Relation of non-alcoholic hepatic steatosis to early carotid atherosclerosis in diet-controlled impaired glucose tolerance subjects. Clin Ter2012; 163: 205–210.
75.
PaisRBellentaniSBugianessiE, et al.1355 Histological severity independently predicts early atherosclerotic lesions and 10 year cardiovascular risk in NAFLD patients. J Hepatol2013; 58: S545.
76.
PetitJMGuiuBTerriatB, et al.Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients. J Clin Endocrinol Metab2009; 94: 4103–4106.
77.
PinarbaşiBDemırKOflazH, et al.Measurement of the coronary flow velocity reserve in patients with non-alcoholic fatty liver disease. Turk J Gastroenterol2012; 23: 720–726.
78.
PoantaLIAlbuAFodorD. Association between fatty liver disease and carotid atherosclerosis in patients with uncomplicated type 2 diabetes mellitus. Med Ultrason2011; 13: 215–219.
79.
PuigJBlascoGDaunisIEJ, et al.Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity. Clin Endocrinol (Oxf)2015; 83: 180–186.
80.
RamilliSPretolaniSMuscariA, et al.Carotid lesions in outpatients with nonalcoholic fatty liver disease. World J Gastroenterol2009; 15: 4770–4774.
81.
RampallyVBiriSKNairIK,et al.Determination of association between nonalcoholic fatty liver disease and carotid artery atherosclerosis among nondiabetic individuals. J Family Med Prim Care2020; 9: 1182.
82.
SalviPRuffiniRAgnolettiD, et al.Increased arterial stiffness in nonalcoholic fatty liver disease: the cardio-GOOSE study. J Hypertens2010; 28: 1699–1707.
83.
Sanei-SistaniSElahifarMAJavadi-NodehiS,et al.Sonographic evaluation of mean carotid intima-media thickness of patients with moderate to severe nonalcoholic fatty liver disease. ZJRMS2011; 42: 35–38.
84.
SatoMKamadaYTakedaY, et al.Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects. Liver Int2015; 35: 925–935.
85.
Serra-PlanasEAguileraECastroL, et al.Low prevalence of non-alcoholic fatty liver disease in patients with type 1 diabetes is associated with decreased subclinical cardiovascular disease. J Diabetes2017; 9: 1065–1072.
86.
SertAAyparEPirgonO, et al.Left ventricular function by echocardiography, tissue Doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease. Am J Cardiol2013; 112: 436–443.
87.
EMSAAMFaroukA,Non-alcoholic fatty liver disease as a cardiovascular risk factor. El-Minia Medical Bulletin2010; 21(1): 26–41.
88.
TargherGBertoliniLPadovaniR, et al.Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care2006; 29: 1325–1330.
89.
TargherGBertoliniLPadovaniR, et al.Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. Diabetes Care2004; 27: 2498–2500.
90.
TargherGBertoliniLPadovaniR, et al.Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients. J Endocrinol Invest2006; 29: 55–60.
91.
TargherGBertoliniLPadovaniR, et al.Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. J Hepatol2007; 46: 1126–1132.
92.
TarnokiADTarnokiDLBataP, et al.Heritability of non-alcoholic fatty liver disease and association with abnormal vascular parameters: a twin study. Liver Int2012; 32: 1287–1293.
93.
TorresDParrinelloGPaternaS,et al.Is there a link between liver steatosis, carotid atherosclerosis and C-reactive protein in metabolic and non-metabolic patients?Atherosclerosis2008; 1: 90.
94.
YiXLiuYHZhouXF, et al.The influence of abdominal and ectopic fat accumulation on carotid intima-Media thickness: a Chongqing study. J Stroke Cerebrovasc Dis2018; 27: 1992–1997.
95.
ZhangLGuoKLuJ, et al.Nonalcoholic fatty liver disease is associated with increased carotid intima-media thickness in type 1 diabetic patients. Sci Rep2016; 6: 1–8.
96.
ZhouXGuoZWangC. Research on the carotid artery intima-media thickness in nonalcoholic fatty liver disease. Chinese J Health Care Med2009; 5: 365–367.
97.
WangBZhaoZLiuS, et al.Impact of diabetes on subclinical atherosclerosis and major cardiovascular events in individuals with and without non-alcoholic fatty liver disease. Diabetes Res Clin Pract2021; 177: 108873.. Epub 2021 May 26. PMID: 34051282.
98.
SukahriSMohamed ShahFZIsmailAI, et al.Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease. PLoS One2021; 16: e0253298.. PMID: 34191823; PMCID: PMC8244858.
99.
ShabbirhussainBVSinghSDixitVK, et al.Carotid intima media as predictor of liver fibrosis in type 2 diabetes mellitus with NAFLD. Diabetes Metab Syndr2022; 16: 102560. Epub 2022 Jul 1. PMID: 35816948.
100.
TaharbouchtSGuermazRBrouriM,et al.Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: a case-control study in Algerian population. J Med Vasc2021; 46: 129–138.. Epub 2021 Apr 20. PMID: 33990287.
101.
El AzeemHAKhalekESAEl-AkabawyH, et al.Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events. J Saudi Heart Assoc2013; 25: 239–246.
102.
AçikelMSunaySKoplayM, et al.Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography. Anadolu Kardiyol Derg2009; 9: 273–279.
103.
AllenAMTherneauTMMaraKC, et al.Women with nonalcoholic fatty liver disease lose protection against cardiovascular disease: a longitudinal cohort study. Am J Gastroenterol2019; 114: 1764–1771.
104.
ChanWKTanATVethakkanSR, et al.Ultrasonography-diagnosed non-alcoholic fatty liver disease is not associated with prevalent ischemic heart disease among diabetics in a multiracial Asian hospital clinic population. Clin Res Hepatol Gastroenterol2014; 38: 284–291.
105.
HamaguchiMKojimaTTakedaN, et al.Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol2007; 13: 1579–1584.
106.
IchikawaKMiyoshiTOsawaK, et al.Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study. Cardiovasc Diabetol2021; 20: 1–10.
107.
KaplanASimonTGHensonJB, et al.Brief report: relationship between nonalcoholic fatty liver disease and cardiovascular disease in persons with HIV. J Acquir Immune Defic Syndr2020; 84: 400–404.
108.
LabenzCHuberYMichelM, et al.Impact of NAFLD on the incidence of cardiovascular diseases in a primary care population in Germany. Dig Dis Sci2020; 65: 2112–2119.
109.
LiYZhuSLiB, et al.Association between non-alcoholic fatty liver disease and chronic kidney disease in population with prediabetes or diabetes. Int Urol Nephrol2014; 46: 1785–1791.
110.
LuHZengLLiangB, et al.High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease. Arch Med Res2009; 40: 571–575.
111.
SinnDHKangDChangY, et al.Non-alcoholic fatty liver disease and the incidence of myocardial infarction: a cohort study. J Gastroenterol Hepatol2020; 35: 833–839.
112.
PistoPSantaniemiMBloiguR, et al.Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study. BMJ Open2014; 4: e004973.
113.
StepanovaMYounossiZM. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin Gastroenterol Hepatol2012; 10: 646–650.
114.
TargherGArcaroG. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis2007; 191: 235–240.
115.
TargherGBertoliniLPadovaniR, et al.Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. J Hepatol2010; 53: 713–718.
116.
TargherGPichiriIZoppiniG, et al.Increased prevalence of cardiovascular disease in type 1 diabetic patients with non-alcoholic fatty liver disease. J Endocrinol Invest2012; 35: 535–540.
117.
VitaTMurphyDJOsborneMT, et al.Association between nonalcoholic fatty liver disease at CT and coronary microvascular dysfunction at myocardial perfusion PET/CT. Radiology2019; 291: 330–337.
118.
WongVWWongGLYipGW, et al.Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut2011; 60: 1721–1727.
119.
YangWXuHYuX,et al.Association between retinal artery lesions and nonalcoholic fatty liver disease. Hepatol Int2015; 9: 278–282.
120.
TaylanGEbikMSolakS, et al.Risk of premature coronary atherosclerosis in patients with nonalcoholic fatty liver disease. Rev Assoc Med Bras (1992)2022; 68: 1428–1433. PMID: 36417648; PMCID: PMC9683909.
121.
ChungGEChoEJYooJJ, et al.Young adults with nonalcoholic fatty liver disease, defined using the fatty liver index, can be at increased risk of myocardial infarction or stroke. Diabetes Obes Metab2022; 24: 465–472.. Epub 2021 Dec 1. PMID: 34726318.
122.
AlperATHasdemirHSahinS, et al.The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome. Turk Kardiyol Dern Ars2008; 36: 376–381.
123.
GuoYCZhouYGaoX, et al.Association between nonalcoholic fatty liver disease and carotid artery disease in a community-based Chinese population: a cross-sectional study. Chin Med J (Engl)2018; 131: 2269–2276.
124.
AssyNDjibreAFarahR, et al.Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology2010; 254: 393–400.
125.
IdilmanISAkataDHazirolanT, et al.Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2. J Diabetes2015; 7: 279–286.
126.
PuchnerSBLiuTMayrhoferT, et al.High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain: results from the ROMICAT-II trial. J Am Coll Cardiol2014; 64: 684–692.
127.
TargherGByrneCDLonardoA, et al.Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol2016; 65: 589–600.
128.
GhouriNPreissDSattarN. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology2010; 52: 1156–1161.
129.
WongMYZYapJJLSultanaR, et al.Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis. Open Heart2021; 8(2): e001850.
130.
MontazeriZHashemi-MadaniNIrajiH, et al.Non-alcoholic fatty liver disease and compromised endothelial function in people with type 2 diabetes. BMC Endocr Disord2023; 23: 202.
131.
ZhaoYCZhaoGUChenZ, et al.Nonalcoholic fatty liver disease. Hypertension2020; 75: 275–284.
132.
HernaezRLazoMBonekampS, et al.Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology2011; 54: 1082–1090.
133.
LeeSSParkSH. Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol2014; 20: 7392.
134.
WaiJWFuCWongV. Confounding factors of non-invasive tests for non-alcoholic fatty liver disease. J Gastroenterology2020; 55: 731–741.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
